Download CV_NIR PELED_Jan 2014

Prof. Nir Peled MD PhD
CURRICULUM VITAE
updated 10.01.2014
Nir Peled MD PhD ID 023899461
NAME
Israeli MD LN 26519
Israeli Board Certification in Internal Medicine LN 22022
Israeli Board Certification in Pulmonary Medicine LN 25714
Israeli Board Certificatoin in Medical Oncology
USMLE ECFMG Certification 07254162; USA CO LN 47608
FACULTY/DEPT
Associate Professor
Department of Internal Medicine
Sackler Faculty of Medicine
Tel/Fax: 972 3 5307014
HOSPITAL/DEPT
Thoracic Cancer Unit, Davvidoff Cancer Center
Rabin Medical Center
Kaplan St, Petach Tiqwa, Israel
Tel. No. (mobile): 972-52-6669172
HOME ADDRESS
1 Mazal Kashat St, Hod Hasharon, Israel 45803
Tel. No. (mobile): 972-52-6669172
Email: [email protected] ; [email protected]
DATE AND PLACE
11.12.1968, Tel Aviv, Israel
OF BIRTH
MARITAL
STATUS
Married three children
NO. OF CHILDREN
1
Nir Peled MD PhD FCCP
A. EDUCATION
1986- 1991: Rappaport Faculty of Medicine, Technion – Israel Institute of
Technology, Haifa, Israel. B.Medical Science, Cum Lauda.
1992-1995:
Rappaport Faculty of Medicine, Technion - Israel Institute of
Technology, Haifa, Israel. M.D. Cum Lauda.
1992-1998:
Rappaport Faculty of Medicine, Technion – Israel Institute of
Technology, Haifa, Israel. Ph.D. in Medical Science.
7/00-6/03:
Rabin Medical Center, Tel-Aviv University, Israel.
Residency in Internal Medicine (Israeli Board #22022).
7/05-6/07:
Rabin Medical Center, Tel-Aviv University, Israel.
Residency in Pulmonary Medicine (Israeli Board #25714).
7/07-6/08
Rabin Medical Center, Tel-Aviv University, Israel.
Residency in Medical Oncology.
7/08-6/10
University Colorado Cancer Center (UCCC), University of Colorado
Denver, Denver, CO, USA
Fellowship in Medical Oncology, Thoracic Program (Fulbright
Award).
Mentors: Prof Paul A Bunn, Prof Fred R Hirsch.
M.D. Thesis Sleep on Duty – Behavioral and Physiologic Characteristics
Supervisors Prof Peretz Lavie; Sleep Laboratory, Technion, Haifa, Israel.
PhD Thesis Coexistence of Ischemic Heart Disease and Sleep Apnea Syndrome Clinical Consequences. Sleep Laboratory, Technion, Haifa, Israel.
Supervisors Prof Peretz Lavie and Prof Edward Abinader
2
Nir Peled MD PhD FCCP
B. FURTHER STUDIES
AUG 1994:
Advance Trauma Life Support (ATLS) Training, Medical Corps,
IDF.
DEC 1994:
Hyperbaric Medicine Certification, The Israeli Naval Hyperbaric
Institute, Rappaport Faculty of Medicine, Technion - Israel Institute of
Technology, Haifa, Israel.
NOV 2003:
Radiation safety for work with radioactive material in medical
laboratories, Radiation Safety Division, Soreq Nuclear Radiation
Center, Israel.
AUG 2004:
Medical Effects of Ionizing Radiation (MEIR) Training, Armed
Forces Radiobiology Research Institute (AFRRI), Bethesda Maryland,
USA.
JAN 2006:
Expert Testimony, The Israeli Physician Association, Tel Aviv,
Israel.
NOV 06:
GCP ACRP Training for Pl in Research & Clinical Trials.
Dec 2008:
ECFMG Certification (# 0-725-416-2) (USMLE steps 1,2,3); Medical
License; State of Colorado; USA #47608 (4/16/09 exp 5/21/11); DEA
Certified (exp 03/31/2012).
C. ACADEMIC EXPERIENCE
1999-2004
Directing Sleep Medicine course - “Dina” Academic School for Nursing,
Tel-Aviv University, Israel.
Academic Course Coordinator and Lecturer
1999-2003
Internal Medicine Clerkship – Sackler Faculty of Medicine, Tel-Aviv
University, Israel.
Lecturer
2000-2004
ECG for ICU nursing - Dina Academic School for Nursing, Tel-Aviv
University, Israel.
Academic Course Coordinator and Lecturer
2005
Tutor of Internal Medicine clerkship for 4th year medical students.
Rabin Medical Center, Petach Tiqwa, Sackler Faculty of Medicine, TelAviv University, Israel.
Academic Course Coordinator and Lecturer
2005-2007
Medical students attending in pulmonary medicine, Sackler Faculty of
3
Nir Peled MD PhD FCCP
Medicine, Tel-Aviv University, Israel.
Lecturer
2010-2011
The Hebrew University School of Medicine.
Mentor, Medical Humanity Program
2010-2012
The Hebrew University School of Medicine.
Program Coordinator and Lecturer
2010present
Examiner and Committee Member for the Board Exams for
Pulmonary Medicine, Isreal.
2011-2012
Medical Education - Mentor. The 4th year track of Medicine, Sackler
Faculty of Medicine, Tel-Aviv University, Israel.
2012present
Respiratory Anatomy and Basic Physiology – Course Director; 1st
year; The 4th & 6 years tracks of Medicne, Sackler Faculty of Medicine,
Tel-Aviv University, Israel.
2013present
Associated Professor in Internal Medicine, Full Academic Track,
Sackler Faculty of Medicine, Tel-Aviv University, Israel.
C. CLINICAL EXPERIENCE
1993-1994
Intern. Rambam Medical Center, Haifa, Israel.
1994-1997:
Sleep Physician, Sleep Laboratory, Rambam Medical Center,
Technion - Israel Institute of Technology, Haifa, Israel.
1994-1995
Physician in Parachute battalion, IDF.
1995-1998
Physician of the Israeli Naval Commando Forces, IDF.
1999
Volunteering as a physician in VIETNAM for 6 months, cooperating
with the US Embassy and local children hospital and orphanages.
7/98-6/00:
Pediatric Fellowship – Schneider Children Medical Center, Petach
Tiqwa, Sackler Faculty of Medicine, Tel-Aviv University, Israel.
7/00-6/03:
Internal Medicine Residency (Israeli Board #22022), Recanati
Center, Rabin Medical Center, Petach Tiqwa, Sackler Faculty of
Medicine, Tel-Aviv University, Israel.
7/00-6/08
Sleep Laboratory, Senior Physician. Rabin Medical Center, Petach
Tiqwa , Sackler Faculty of Medicine, Tel-Aviv University, Israel.
7/03-6/05:
Radiation Safety advisor, Medical Corps, IDF.
7/05-6/07:
Pulmonary Medicine Fellowship (Israeli Board #25714), Rabin
4
Nir Peled MD PhD FCCP
Medical Center, Petach Tiqwa, Sackler Faculty of Medicine, Tel-Aviv
University, Israel.
7/07-6/08
Medical Oncology Residency, Davidoff Cancer Center, Rabin
Medical Center, Petach Tiqwa, and Sheba Medical Center, Tel
Hashomer; Sackler Faculty of Medicine, Tel-Aviv University, Israel.
7/08-6/10
Medical Oncology Fellowship (Fulbright Award), Lung Cancer
unit, Anchuz Medical Center, University Colorado Cancer Center
(UCCC), University of Colorado Denver, Denver, CO, USA. Mentors:
Prof Fred Hirsch; Prof Paul A Bunn.
7/11Present
Pulmonologist and Medical Oncologist. Head of the Thoracic
Research and Detection Center, Sheba Medical Center, Tel Aviv
University, Israel.
1/14Present
Pulmonologist and Medical Oncologist. Thoracic Cancers Unit,
Davidoff Cancer Center, Rabin Medical Center & Tel Aviv University,
Israel.
D. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS
1994
The 6th international congress on ambulatory monitoring, Barcelona,
Spain (Poster).
1994
The 12th European Sleep Research Society Congress, Fierenze, Italy
(Posters).
1994
Fourth Word Congress on Sleep Apnea 1994, San Francisco,
California, USA (Poster).
1995
The 2nd Meeting of The Israeli Society for Biological Psychiatry, Kfar
Giladi, Israel (Oral).
1995
The 9th APSS Annual Meeting, Nashville, Tennessee, USA (Oral).
1995
The 1st Congress of the Israeli Sleep Research Society, Netania,
Israel (Posters).
1997
The 8th International Rappaport Congress and the 2nd Israeli Sleep
Research Society Meeting, Zichron Yaacov, Israel (Oral).
1998
The 3rd Annual Meeting of the Israeli Sleep Research Society, Beer
Sheva, Israel (Oral).
1998
The XIII Word Congress of Cardiology, Rio de Janeiro, Brazil
(Poster).
5
Nir Peled MD PhD FCCP
1998
The Annual meeting of the Israeli Heart Society, Jerusaelm, ISRAEL
(Poster).
1998
The 14th Congress of the European Sleep Research Society, Madrid,
Spain (Oral).
1999
ALA/ATS International Conference, San Diego, California, USA.
2004
The 51st Annual Conference of the Israel Heart Society, Tel-Aviv
(Oral).
2005
The Interim Congress of World Federation of Sleep Research and
Sleep Medicine Societies, New Delhi, India (Oral).
2006
The Annual Scientific Meeting of the Israeli Society of Pulmonolgy
and the Israeli Society of Thoraci Surgery, Deat sea, Israel (Oral).
2006
The Annual International Conference of the American thoracic
Society, San Diego, California, USA (Poster).
2006
The Annual International Conference of the Eropean Thoracic
Society, Minch, Germany (Oral).
2006
The 8th Annual Meeting of the Israeli Sleep Research Society, HaifaIsrael, Israel (Oral).
2007
The 3rd Annual Update Symposion Series on Clinical Neurology and
NeuroPhysiology, Tel Aviv, Israel (Invited Guest Speaker).
2007
The Annual Scientific Meeting of the Israeli Society of Pulmonolgy
and the Israeli Society of Thoraci Surgery, Keisaria, Israel (Oral).
2007
The SLEEP 2007 Meeting (APSS), Minneapolis, MN, USA (Oral and
Young Investigator Honor Mention Award).
2007
The European Respiratory
Stockholm, Sweden (Poster).
2007
The 10th Annual Meeting of the Israeli Sleep Research Society, BeerSheva, Israel (Oral).
2008
The Annual 7th Meeting of the Israeli Society for Clinical Oncology
and radiation Therapy, Eilat, Israel (Poster).
2008
The 44th Annual Meeting of the American Society of Clinical
Oncology, Chicago, USA (Poster).
2008
The European Society for Medical Oncology Conference, Lugano,
Switzerland (Poster).
2008
The 33rd ESMO Congress, Stockholm, Sweden (Poster).
2009
The 2009 ATS International Conference in San Diego, CA, USA
6
Society
Annual
Congress
2007,
Nir Peled MD PhD FCCP
(Poster).
2009
The 2009 IASLC International Conference in San Francisco, CA, USA
(Oral, e-poster and Press released).
2010
The 2010 IASLC UC Denver Cancer Center Retreat in Westminster,
CO, USA (Poster Session Award).
2010
The 2010 ASCO International Conference in Chicago, IL, USA
(ASCO Cancer Foundation Merit Award).
2010
The 2010 CHEST International Conference in Vancouver BC,
Canada (Oral, Invited Talk and Pannel Discussion).
2011
The Second Annual Westcliffe Pulmonary Conclave; Westcliffe,
Colorado; USA (Oral, Invited).
2011
The 14th World Conference of Lung Cancer (IASLC); Amsterdam,
Neatherland, July 2011 (Chair & Oral).
2011
The 25th International Conference on Screening for Lung Cancer. IELCAP; Jerusaelm, Israel, October 2011 (Oral, Invited).
2012
The AACR-IASLC Joint Conference on Molecular Origins of Lung
Cancer: Biology, Therapy, and Personalized Medicine; San Diego,
CA USA. January 2012 (Two Original studies, Posters; Scorred by
“MedPage
Today
http://www.medpagetoday.com/MeetingCoverage/AACRIASLC/30582)
2012
The European Respiratory Society Congress, Vienna September
2012 (Chair + Thematic Poster).
2013
The 1st International Congress on Controversies in Personalized
Oncology: Breast, Colon, Lung, Melanoma (CONPO). Barcelona,
Spain. March, 8-9, 2013. (Paticipation only).
2013
The International Society for Olfactory and Chemical Sensing Annual
Meeting; Wallerfangen, Germany. Course for Chemical Sensors for
Breath Analysis. June 13-14, 2013 (Orgenizer and Oral).
2013
The Israeli Chest Physicians Annual Scientific Meeting. EML4-ALK
Gene Rearangement in NSCLC Patients – The Hidden 50%. Tel Aviv,
Israel. June 19th, 2013 (Oral+Award).
2013
Corsos de Verano; Summer Seminar by UNIVERSIDAD
COMPLUTENSE MADRID; San-Lorenzo de El-Escorial, Spain.
“Novel Technologies for Early Detection Of Lung Cancer”. July 2 nd
2013 (Oral, Invited).
2013
The European Respiratory Society. Barcelona, Spain. September 77
Nir Peled MD PhD FCCP
12, 2013 (Chairman, Orals and Posters)
2013
The 1st Indian Cancer Conference, Invited Talk, Chairman and
Round Table leader, New Delhi, November21st-24th, 2013.
2014
The 13th Annual Meeting of the Israeli Society for Clinical Oncology
and Radiotion Therapy; January, 14-17, 2014 (3 oral presentations &
Award).
D. Chairman in International Conferences
2006
The 9th Annual Meeting of the Israeli Sleep Research Society, HaifaIsrael.
2007
The 10th Annual Meeting of the Israeli Sleep Research Society, BeerSheva, Israel.
2010
The CHEST 2010 ACCP meeting; Moderator for: Bronchoscopy and
Interventional Procedures: Malignant Disease Posters; Vancouver
BC, Canada.
2010
The CHEST 2010 ACCP meeting; Panel Discussion; Session Title:
Early Detection of Lung Cancer: Is There a True Divining Rod?
Vancouver BC, Canada.
2011
The 14th World Conference of Lung Cancer (IASLC); Amsterdam,
Neatherland, July 2011. Breath test as a Biomarker for Cancer, Lung
Cancer Biomarker Workshop, Chair.
2012
The European Respiratory Society Congress, Vienna September
2012. Session titile: New aspects of lung cancer biology, September
2nd 2012.
2013
The International Society for Olfactory and Chemical Sensing
Annual Meeting; Wallerfangen, Germany. Course for Chemical
Sensors for Breath Analysis. Orgenizer, June 13-14, 2013.
2013
The European Respiratory Society Congress, Barcelona,
September 2013. Chair, Symposium: Early detection of lung cancer.
2013
The 1st Indian Cancer Conference, Invited Talk, Chairman and
Round Table leader, New Delhi, November21st-24th, 2013.
D. Media
8
Nir Peled MD PhD FCCP
2009
Interview by Medscape Oncology (http://www.medscape.com/home) Topic:
Breath analysis for detection of lung cancer representing the IASLC;
January 2009
2009
Interview by NBC; 9News, Colorado (Ward Lucas). Topic: Breath
analysis for early detection of lung cancer. Device "smells" cancer.
Ward Lucas reports. 9NEWS at 10 p.m. 2/22/09
2009
Front page article, “The Denver Post”; Title: Life and Breath”; March,
2nd, 2009
2009
Interview by CBS news: “Cancer Breath” by Shaun Boyd.
Broadcasted in Colorado, San Francisco, Philadelphia, Chicago and
Minneapolis (by KPIX-TV; WCBS-TV; KDKA-TV; KSWT-TV; WCCOTV; WBBM-TV; KYW-TV; WFOR-TV; KTVT-TV), March 2nd – 4th ;
2009.
2009
CBS news; Dallas; Texas: Breat Test might be future of cancer
detection; March, 3rd, 2009.
2009
US Department of State, Bureau of Educational and Cultural Affairs;
Fulbright.state.gov
website
–
Profile;
April
2009;
http://fulbright.state.gov/participating-countries/middle-east-and-northafrica/israel/peled.html
2009
Israel Fulbright Newsletter – Interview, Early detection of for lung
cancer. June 2nd 2009.
2009
Press Conference: Early detection and prevention of lung cancer
during the the 13th World Conference on Lung Cancer (WCLC) at San
Francisco; August 2nd 2009; The study got 21% of the conference’s
media coverage and was the 2nd most covered (SPECTRUM analysis
for Top Studies coverage breakdown). In addition, the study was
cetited by Medscape Conference Coverage as “Top Stories” of
MEDSCAPE PULMONARY MEDICINE MEDPULSE:
More sensitive
“Electronic
Nose”
detected
lung
cancer
from
breath
http://www.medscape.com/viewarticle/706865?src=emailthis
2012
Press Review: The AACR-IASLC Joint Conference on Molecular
Origins of Lung Cancer: Biology, Therapy, and Personalized
Medicine;
San Diego, CA USA. January 2012 by “MedPage Today: Breath Test
Sniffs Out Lung Cancer;
http://www.medpagetoday.com/MeetingCoverage/AACRIASLC/30582)
2012
Press
Review:
“Breath
9
Markers May Improve
Lung Cancer
Nir Peled MD PhD FCCP
Screening”, Thoracic Surgery News by American Association for
Thoracic Surgery. March 13th 2012.
http://www.thoracicsurgerynews.com/specialty-focus/generalthoracic-lung/single-article-page/breath-markers-may-improve-lungcancer-screening/ae9dcb7f07005d85b2504672c7f225ad.html
2012
Detecting Lung Cancer With Nanotechnology. Medscape Medical
News in Oncology. September 18th 2012.
2012
Breath analysis identified malignant pulmonary nodules. HemOnc
today; USA. November 21st, 2012.
2012
Personalized Medicne in Oncology – Breakthrough in Lung Cancer.
TV Channel 1 “Mabat Sheni”, The Israel Broadcasting TV.
December 19th 2012.
2013
Screening for Lung Cancer, Series of articles, Journals (Yediot &
Maariv).
E. ACADEMIC AND PROFESSIONAL AWARDS
E. AWARDS
1991
Cum Lauda Award in Medical Science (B.Sc.), Rappaport Faculty of
Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
1993
Dean Award for Medical Thesis, Rappaport Faculty of Medicine,
Technion - Israel Institute of Technology, Haifa, Israel.
1995
Cum Lauda Award, MD Degree, Rappaport Faculty of Medicine,
Technion - Israel Institute of Technology, Haifa, Israel.
1997
Outstanding Officer, Medical Corps, IDF.
2007
Young Investigators Honorable Mention Award, American Academy of
Sleep Medicine (AASM), SLEEP 2007 meeting, Minneapolis, MN,
USA.
2008-2010 International Association for the Study of Lung Cancer (IASLC)
Fellowship/Young Investigator Award.
2010
University of Colorado Denver, Cancer Center Retreat - Poster Award
(1st prize).
2010
2010 ASCO Cancer Foundation Merit Award.
2013
The Israel Society of Pulmonology; The Annual Scientific Meeting.
10
Nir Peled MD PhD FCCP
Research Award. (1st Prize 7,500 NIS). EML4-ALK gene
rearrangement in NSCLC patients the hidden 50%
2014
The 13th Annual Meeting of the Israeli Society for Clinical Oncology
and Radiotion Therapy; January, 14-17, 2014. The Best of ISCORT
Award (Breath analysis as a non-invasive biomarker for solitary pulmonary
nodules).
E. GRANTS and SCHOLARSHIPS
1993
The Committee for Research & Prevention in Occupational Safety &
Health, Ministry of Labor & Social Affairs: Sleep on Duty - Behavioral
and Physiologic Characteristics (PI: Prof Peretz Lavie).
2008-2009 FULBRIGHT - Schneider Yehuda Danon Post-Doctor Fellow by the
United State – Israel Education foundation- Early Detection of Lung
Cancer by a Novel Breath Analysis; $25,000
2008-2010 International Association for the Study of Lung Cancer (IASLC)
Fellowship/Young Investigator Award/Grant; $80,000
2010-2015 FP7 European Grant of 619,170 € out of 5,405,174 € "A Nanoscale
Artificial Nose to easily detect Volatile Biomarkers at Early stages of
Lung Cancer and Related Genetic Mutations". CO-PI.
2011-2012 Sheba Medical Center - Excellency in Research Award (PI); Israel
$100,000
2011-2012 Israel Cancer Association Grant (PI); Topic: Non Invasive techniques
for the early detection of lung cancer – circulating tumor cells and
exhaled breath nano-analysis 25,000 NIS
2011-2012 Optimata Ltd Research Grant (PI); Topic: Lung cancer therapy:
mathematical model for a better efficacy and safety. $20,000
2012
Tel Aviv University; Faiengraut Carol and Leonara Cancer Grant;
(PI) Non Invasive Biomarkers for the Early Detection of Lung Cancer.
$10,000
2012
VisionGate3D Inc Collaborative Grant (PI). Sputum Analysis for
early detection of Lung Cancer. $30,000
2012
Sheba Medical Center – CRO Italy, Collaborative Granton Cancer
Research. Bench to Bediside, Intramural Grants (PI). Personalized
Based in-silico Modeling for Lung Cancer Therapy. 10,000 €
2012
Teva Israel Grant Support (PI). ALK-EML4 detection by IHC. A Proof
11
Nir Peled MD PhD FCCP
of Concept Study. 15,000 NIS
2013
Israel Cancer Association Grant (PI); Topic: Non Invasive Biomarker
Panel for Early Detection of Lung Cancer 45,000 NIS
2013
Sheba Medical Center – Novelty Grant Support. The Warbur Effect
in Lung Cancer (PI). $10,000
2013
Israel Cancer Association Grant (PI); Topic: A novel technology for
isolation Circulating Tumor Cells as a biomarker for early detection and
treatment effectiveness measure in Lung Cancer 25,000 NIS
F. MEMBERSHIP IN PROFESSIONAL SOCIETIES
1995-present The Israeli Sleep Research Society –Scientific Committee (2006-9).
1998-2006:
The Israeli Society for Hyperbaric and Diving Medicine&Physiology.
2004-2006:
The Israel Society for Radiation Protection (National Commitee).
2007-2010:
The American Academy of Sleep Medicine (AASM)
2005-present The Israeli Respiratory Society - Board Exams for Pulmonary
Medicine - Committee member.
2006-present International Association for the Study of Lung Cancer (IASLC); Early
Detection & Prevention Committee; 2013: Chair of the Committee
2009-present The American Association of Chest Physician (ACCP; FCCP).
2010-2012
The Professional committee for respiratory and sleep equipment
evaluation, Clalit Health Services; Israel.
2009-present American Association for Cancer Research (AACR).
2012Present
The European Respiratory Society (ERS); Member in the Thoracic
Oncology Assembly
E. PATENTS
2010
Volatile Organic Compounds For Detecting Cell Dysplasia And
Genetic Alterations Associated With Lung Cancer.
PCT/IL11/000667; WO2012023138 A3, Auguest 17th, 2011.
2011
Breath Analysis of Pulmonary Nodules. US PROVISIONSAL, NOVEMBER 2011;
US20130150261 A1.
12
Nir Peled MD PhD FCCP
2013
2013
SHEBA METABOLIC
SHEBA CPAP
F. INTERNATIONAL COMMITTEES and EDITORIAL BOARDS
2009-Present Prevention, Screening & Early detection Committee member of the
International Association for the Study of Lung Cancer (IASLC)
2013-Present: CHAIR, EARLY DETECTION & PREVENTION COMMITTEE, IASLC
2010-present Faculty, “CCO Oncology inPractice” CME program.
2011-present Frontiers in Pharmacotherapy of Neoplastic Diseases – Editorial
Board
2012-Present IRSUSAL01, an international protocol to correlate the utility of
PETCT, serum, sputum, and breath technologies to improve early
detection and cure rates in lung cancer; Israel-Florida Collaboration;
PI.
2013-Present The Eropean respiratory Society (ERS) – Member in the Thoracic
Oncology Assembly.
F. GRANTS REVIEW
2009
Review for the Emmanuel van der Schueren Foundation, Brussels;
Belgium
2011
Fullbright Scientific Committee for Excellency (Israel-US Embassy)
2011-Present The Israeli Cancer Association, Israel.
2012-Present Israel Science Foundation, Israel.
2013
Thiel Foundation, Breakout Labs, SF, CA USA.
2013
Cancer Research UK.
F. Referee for Scientific Journals
1. Am J Respir Critical Care Medicine.
2. Cancer.
3. Chest.
4. Journal of Thoracic Oncology
5. Lung Cancer
6. ACS Nano.
7. Respiratory Medicine.
8. Cancer Investigation.
9. Sleep.
10. Epilepsia.
11. Sleep Medicine.
12. Israel Medical Association Journal.
13
Nir Peled MD PhD FCCP
13. Harefuah.
14. Clinical Endocrinology.
15. The Laryngoscope.
16. International Journal of Nanomedicine
17. Fronties Pharmacology.
G. Doctoral & Post-Doctoral & Medical students supervised
2000
2004
2006
2011
2011
2011
2011
2011
2011
2011
2012
Dr. Gidi Bachar, M.D. Thesis: Psychophysiological changes
associated with the nocturnal sleep gate. Graduated at the Thechnion
– Israeli Institute of Technology, 2000 (Codirecting with Prof Peretz
Lavie).
Dr. Heftzi Oren. M.D. Thesis: Melatonin and seizure activity in children
with intractable seizures. Graduated at the Sackler Faculty of Medicine,
Tel-Aviv University, Israel, 2004 (Codirectoring with Prof Ben Zion
Garty).
Dr. Alon Abraham, Basic Science of Nerology residency. Thesis:
Nocturnal carbon Dioxide monitoring in patients with idiopathic
intracranial hypertension.
Dr. Tamar Rashal, Basic Science of Internal Medicine residency.
Sackler Faculty of Medicine, Tel Aviv University, Israel. Thesis: The
role of CRM1 in lung cancer.
Dr. Maya Ilouze, Post Doc Thesis: The Metabolic Road Map for Early
Detection of Lung Cancer. Sackler Faculty of Medicine, Tel-Aviv
University, Israel.
Dr. Daniel Reinhorn, MD Thesis. Rappaport School of Medicine,
Technion Inst. Haifa, Israel. Thesis: Cancer Incidence in Obstructive
Sleep Apnea Syndrome.
Idan Barzilay, MD Thesis. Rappaport School of Medicine, Technion
Inst. Haifa, Israel. Thesis: Early detection of lung cancer through noninvasive biomarkers.
Irit Katz, MD Thesis. Sackler Faculty of Medicine, Tel-Aviv University,
Israel. Rescue Medication Quantification Derived from Electronic
Pharmacy Data as a Marker for Asthma Control.
Inbar Nerdi Agmon, MD Thesis. The Hadassah School of Medicine,
The Hebrew University, Jerusalem, Israel. Exhaled Volatile Organic
Compounds (VOCs) signature in Lung Cancer Therapy.
Ronen Shavit, MD Thesis and Arrow Project (Sheba Medical
Center). Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Radio-sensitizing lung cancer cells by increasing mitochondrial activity.
Marina Peker, MD Thesis. Sackler Faculty of Medicine, Tel-Aviv
14
Nir Peled MD PhD FCCP
University, Israel. ALK-EML4 translocation in NSCLC – FISH vs. IHC.
Tali Feinberg, PHD Student. Sackler Faculty of Medicine, Tel-Aviv
University, Israel.
Ori Liran, MD Thesis and Arrow Project (Sheba Medical Center).
Sackler Faculty of Medicine, Tel-Aviv University, Israel. Thesis:
Personalized Medicine in Lung Cancer – in silico Model for better
efficacy and toxicity profile.
Layah Alkoby, MD Thesis. Sackler Faculty of Medicine, Tel-Aviv
University, Israel. The Contribution of the FDG PET scan and induced
Glycolysis to the Exhaled Volatile Organic Compounds (VOCs)
signature in Lung Cancer.
Yossi Tzur, MD Thesis and Arrow Project (Sheba Medical Center).
Sackler Faculty of Medicine, Tel-Aviv University, Israel. Employment
exposure to cytotoxic drugs and cancer incidence among healthcare
workers in Israel.
Tina Wexler, MD Studant, Arrow Program. Sackler Faculty of
Medicine, Tel-Aviv University, Israel. Gene expression for the Warbur
Effect in Cancer Cells.
Svetlana Kulik, Msc Thesis. EML4-ALK Rearrangment in Lung
Cancer. Diagnostic Methods. Sackler Faculty of Medicine, Tel-Aviv
University, Israel
2012
2012
2012
2012
2013
2013
Other tutorial experience
1986-91:
Directing 50 advisors of disadvantage youth at Yokneam, Israel.
SCIENTIFIC PUBLICATIONS
A. BOOKS AND MONOGRAPHS
B.1. ORIGINAL ARTICLES
1.
Ishay JS(PI), Peled N(C), Tishler IR(T), Rosenzweig E(C).
Photoconductivity in hornet cuticle: A theoretical approach.
Physiological Chemistry and Physics and Medical NMR 19:101-115,
1987.
2.
Pillar G(C), Peled N(C), Katz N(C), Lavie P(PI).
Prediction value of specific risk factors, symptoms and signs in diagnosis
obstructive sleep apnea syndrome and its severity.
J Sleep Research 3:241-244, 1994.
(PMID: 10607131; NEUROSCIENCES 36/167 IF:3.5)
15
Nir Peled MD PhD FCCP
3.
Pillar G(PI)., Peled N(C)., Katz N(C)., Peled R(C)., Lavie P(C).
Sleep disorders in the obese.
Harefuah 127(1-2): 27-31, 1994.
(PMID: 7959384)
4.
Kwon OJ(C), Peled N(PI), Miller K(C), Pillar G(C), Peled R(C), Lavie P(C),
Brautbar C(C), Amar A(C).
HLA Class II Analysis in Jewish Israeli Narcoleptic Patients.
Human Immunology 44:199-202, 1995.
(PMID: 8770632; IMMUNOLOGY 71/128; IF:2.55)
5.
Pillar G(PI), Schnall R(T), Peled N(C), Oliven A(C), Lavie P(C).
Impaired respiratory response to resistive loading during sleep in healthy
offspring of patients with obstructive sleep apnea.
Am J Respir Critical Care Med 155:1602-1608, 1997.
(PMID: 9154864; RESPIRATORY SYSTEM 1/43 IF:10.7)
6.
Peled N(PI), Greenberg A(C), Pillar G(C), Zinder O(C), Levi N(T), Lavie P(C).
Contributions of hypoxia and Respiratory Disturbance Index to
sympathetic activation and blood pressure in obstructive sleep apnea
syndrome.
American J Hypertension 11:1284-1289, 1998.
(PMID: 9832170; PERIPHERAL VASCULAR DISEASE 19/61; IF: 3.04)
7.
Peled R(PI), Pillar G(C), Tov N(C), Peled N(C), Lavie P(C).
Recording nocturnal erections following injuries and insurance claims:
cost-effectiveness.
Harefuah 136:432-434, 1999.
(PMID: 10914256)
8.
Peled N(PI), Abinader EG(C), Pillar G(C), Sharif D(C), Lavie P(C).
Nocturnal ischemic events in patients with obstructive sleep apnea
syndrome and ischemic heart disease: Effect of continuous positive air
pressure treatment.
J American College of Cardiology, 34(6):1744-1749, 1999.
(PMID: 10577565; CARDIAC & CARDIOVAS. SYSTEMS 2/95;
IF:12.64).
9.
Pillar G(PI), Shahar E(T), Peled N(C), Ravid S(C), Lavie P(C), Etzioni A(C).
Melatonin improves sleep-wake patterns in psychomotor retarded
children. Pediatric Neurology, 23:225-228, 2000.
(PMID: 11033284; PEDIATRICS 46/94; IF:1.497).
10.
Peled N(PI), Shorer Z(C), Peled E(C), Pillar G(C).
Melatonin effect on seizures in children with severe neurologic deficit
disorders.
Epilepsia, 42(9): 1208-1210, 2001.
16
Nir Peled MD PhD FCCP
(PMID: 11580772; CLINICAL NEUROLOGY 23/167; IF 4.052).
11.
Peled N(PI), Amar A(C), Peled E(C), Brautbar C(C), Pillar G(C).
DRB1*1502-DQB1*0601-DQA1*0103 and DRB1*04-DQB1*0302
Jews Hypersomnolent patients.
J Sleep Medicine, 3:267-270, 2002.
(PMID: 14592217; CLINICAL NEUROLOGY 29/167; IF:3.699).
in
12.
Fisher D(PI), Pillar G(C), Malhotra A(C), Peled N(C), Lavie P(C).
Long-tern follow-up of untreated patients with Sleep Apnoea Syndrome.
Respiratory Medicine, 96(5):337-343, 2002.
(PMID: 12113384; RESPIRATORY SYSTEM 21/43 IF:2.33)
13.
Pillar G(PI), Schuscheim G(C), Weiss R(C), Malhotra A(C), McCowen KC(C),
Shlitner A(C), Peled N(C), Shehadeh N(C).
Interactions between hypoglecemia and sleep architecture in children
with type 1 diabetes mellitus.
J Pediatrics, 142(2):163-168, 2003.
(PMID: 12584538; PEDIATRICS 3/94; IF:4.687).
14.
Pillar G(PI), Averbooch E(C), Katz N(C), Peled N(C), Kaufman Y(C), Shahar
E(C). Prevalence and risk of sleep disturbances in adolescents after
minor head injury.
Pediatric Neurology, 29 (2):131-135, 2003.
(PMID: 14580656; PEDIATRICS 46/94; IF:1.497).
15.
Peled N(PI), Huberman H(C), Scherf E(C), Zmira S(C), Nakar C(C), Garty
B(C). Adenovirus infection in hospitalized immunocompetent children.
Clinical Pediatric, 43:223-229, 2004.
(PMID: 15094946; PEDIATRICS 66/94; IF 0.977).
16.
Adir Y(C), Shupak A(C), Gil A(C), Peled N(PI), Keynan Y(C), Weiler-Ravell
D(C). Swimming-induced pulmonary edema: clinical presentation and
serial lung function.
Chest, 126(2):394-399, 2004.
(PMID: 15302723; RESPIRATORY SYSTEM 3/43; IF:6.360).
17.
Bishara J(PI), Peled N(C), Samra Z(C), Sagie A(C), Leibovici L(C), Pitlik S(C).
Infective endocarditis in diabetic and non-diabetic pateints.
Scandinavian J Infectious Disease, 36:795-798, 2004.
(PMID: 15764163; INFECTIOUS DISEASES 44/57; IF:1.70).
18.
Samra Z(C), Yardeni M(C), Peled N(C), Bishara J(PI).
Species distribution and antifungal susceptibility of Candida bloodstream
isolates in a tertiary medical center in Israel.
Eur J Clin Microbiol Infect Dis, 24(9):592-595, 2005.
(PMID: 16172856; INFECTIOUS DISEASES 25/57; IF:2.605).
17
Nir Peled MD PhD FCCP
19.
Shitrit D(PI), Peled N(C), Shitrit AB(C), Meidan S(C), Bendayan D(C), Sahar
G(C), Kramer MR(C).
An association between oxygen desaturation and D-dimer in patients
with obstructive sleep apnea syndrome.
Thrombosis and Haemostasis, 94(3):544-547, 2005.
(PMID: 16268470; PERIPHERAL VASCULAR DISEASE 11/61; IF:
4.451).
20.
Peled N(PI), Pitlik S(C), Livne G(C), Ashkenazi S(C), Bishara J(C).
Impact of age on clinical features and outcome of infective endocarditis.
European Journal of Clinical Microbiology & Infectious Diseases,
25:473-475, 2006.
(PMID: 16773390; INFECTIOUS DISEASES 25/57; IF:2.605).
Times Cited: 6 (from Web of Science)
21.
Peled N(PI), Shitrit D(C), Bendayan D(C), Kramer MR(C).
Right upper lobe “Window” in right bronchus metal Stenting.
European J Cardio Thoracic Surgery 30:680-682, 2006.
(PMID: 16949831; SURGERY 40/167; IF: 2.397).
Times Cited: 2 (from Web of Science)
22.
Peled N(PI), Shitrit D(C), Bendayan D(C), Peled E(C), Kramer MR(C).
Association of elevated levels of vascular endothelial growth factor in
obstructive sleep apnea syndrome with patient's age rather than with
obstructive sleep apnea syndrome severity.
Respiration 74(1):50-5, 2007.
(PMID: 16954652; RESPIRATORY SYSTEM 26/43; IF:1.935).
Times Cited: 10 (from Web of Science)
23.
Peled N(PI), Pitlik S(C), Samra Z(C), Kazakov A(C), Bloch Y(C), Bishara J(C).
Predicting Clostridium difficile Toxin in Hospitalized Patients With
Antibiotic-Associated Diarrhea.
Infection Control and Hospital Epidemiology, 28(4):377-81, 2007.
(PMID: 17385141; PUBLIC, ENVIRONMENTAL & OCCUPATIONAL
HEALTH 28/122; IF:2.768).
Times Cited: 18 (from Web of Science)
24.
Peled N(PI), Kassirer M(C), Shitrit D(C), Kogan Y(C), Shlomi D(C), Berliner
AS(C), Kramer MR(C).
The association of OSA with insulin resistance, inflammation and the
metabolic syndrome.
Respiratory Medicine, 101(8):1696-1701, 2007.
(PMID: 17466499; RESPIRATORY SYSTEM 21/43 IF:2.33)
Times Cited: 37 (from Web of Science)
25.
Bishara J(PI), Hadari N(C), Shalita-Chesner M(C), Samra Z(C), Ofir O(C),
Paul M(C), Peled N(C), Pitlik S(C), Molad Y(C).
Soluble triggering receptor expressed on myeloid cells-1 for
18
Nir Peled MD PhD FCCP
distinguishing bacterial from aseptic meningitis in adults.
Eur J Clin Microbiol Infect Dis, 26(9):647-50, 2007.
(PMID: 17610097 ; INFECTIOUS DISEASES 25/57 ; IF: 2.605).
Times Cited: 9 (from Web of Science)
26.
Shitrit D(PI), Priess R(C), Peled N(C), Bishara G(C), Shlomi D(C), Kramer
MR(C).
Differentiation of Mycobacterium kansasii infection from
Mycobacterium tuberculosis infection: comparison of clinical features,
radiological appearance, and outcome.
Eur J Clin Microbiol Infect Dis, 26:679-684, 2007.
(PMID: 17629758 ; INFECTIOUS DISEASES 25/57 ; IF: 2.605)
Times Cited: 11 (from Web of Science) .
27.
Shitrit AB(PI), Braverman D(C), Stankiewics H(C), Shitrit D(C), Peled N(C),
Paz K(C).
Fecal calpoprotectin as as predictor of abnormal colonic histology.
Diseases of the Colon & Rectum, 50(12):2188-93, 2007.
(PMID: 17963005; SURGERY 36/167; IF:2.536).
Times Cited: 12 (from Web of Science)
28.
Peled N(PI), Shitrit D(C), Bendayan D(C), Kramer MR(C).
Azythromycin in bronchiolitis obliterans syndrome.
Harefuah, 146(3):219-222, 2007.
(PMID: 17460931)
29.
Peled N(PI), Kassirer M(C), Rogowski O(C), Shlomi D(C), Fox B(C), Berliner
AS(C), Kramer MR(C), Shitrit D(C).
Increased erythrocyte adhesiveness and aggregation in obstructive
sleep apnea syndrome.
Thrombosis Research, 121:631-636, 2008.
(PMID: 17904204; PERIPHERAL VASCULAR DISEASE 27/61;
IF:2.406).
Times Cited: 14 (from Web of Science)
30.
Bishara J(PI), Peled N(C), Pitlik S(C), Samra Z(C).
Mortality of patients with antibiotic-associated diarrhoea: the impact of
Clostridium difficile.
Journal of Hospital Infection; 68:308-314, 2008.
(PMID: 18353491; INFECTIOUS DISEASES 18/57; IF:3.012).
Times Cited: 22 (from Web of Science)
31.
Fox B(PI), Krylov Y(C), Leon P(C), Peled N(C), Ben-Zvi I(C), Shitrit D(C),
Kramer MR(C).
Benzodiazepine and opioid sedation attenuate the sympathetic response
to fiberoptic bronchoscopy. Prophylactic labetalol gave no benefit.
Results of a randomized double blind placebo controlled study.
Respiratory Medicine, 102(7):978-83, 2008.
(PMID: 18394874; RESPIRATORY SYSTEM 21/43 IF:2.33)
19
Nir Peled MD PhD FCCP
Times Cited: 7 (from Web of Science)
32.
Ollech J(PI), Kramer MR(C), Peled N(C), Amital A(C), Medalion B(C), Saute
M(C), Shitrit D(C).
Post transplant diabetes mellitus in lung transplant recipients: Incidence
and risk factors.
European J Cardiothoracic Surgery, 33(5):844-8, 2008.
(PMID: 18339554; RESPIRATORY SYSTEM 19/43; IF:2.397).
Times Cited: 18 (from Web of Science)
33.
Shlomi D(PI), Peled N(C), Shitrit D(C), Bendayan D(C), Amital A(C), Kramer
MR(C).
Protective effect of immunosupression on granulation tissue formation
metallic stents.
Laryngoscope, 118(8):1383-1388, 2008.
(PMID: 18496158; OTORHINOLARYNGOLOGY 7/36; IF:2.018).
Times Cited: 4 (from Web of Science)
34.
Fox BD(PI), Nachum IB(C), Bernstine H(C), Amital A(C), Bakal I(C), Peled
N(C), Shitrit D(C), Kramer MR(C).
Graft side-mismatching for single-lung transplantation does not affect
outcomes: role of the pre-operative quantitative lung perfusion scan.
J Heart Lung Transplantation, 27(3):272-5, 2008.
(PMID: 18342748; TRANSPLANTATION 5/24 IF:3.541)
Times Cited: 1 (from Web of Science)
35.
Maoz C(PI), Shitrit D(C), Samra Z(C), Peled N(C), Kaufman L(C), Kramer
MR(C), Bishara J(C).
Pulmonary Mycobacteruim Simiae infection. Comparison with pulmonary
tuberculosis.
European J Clin Microbiology & Infectious Dis. 27(10):945-50, 2008.
(PMID: 18488259; INFECTIOUS DISEASES 25/57; IF:2.605)
Times Cited: 6 (from Web of Science)
36.
Shitrit D(PI), Gershman Y(C), Peled N(C), Medalion B(C), Saute M(C), Amital
A(C), Kramer MR(C).
Risk factors for death while awaiting lung transplantation in Israeli
patients: 1997-2006.
European J of Cardiothoracic Surgery; 34(2):444-448, 2008.
(PMID: 18495487; RESPIRATORY SYSTEM 19/43; IF:2.397).
Times Cited: 3 (from Web of Science)
37.
Rusanov V(PI), Shitrit D(C), Fox B(C), Amital A(C), Peled N(C), Kramer
MR(C). Use of the 15-steps climbing exercise oximetry test in patients
with idiopathic pulmonary fibrosis.
Respiratory Medicine, 102(7):1080-8, 2008.
(PMID: 18457939; RESPIRATORY SYSTEM 21/43 IF:2.33)
Times Cited: 6 (from Web of Science)
20
Nir Peled MD PhD FCCP
38.
Shitrit D(PI), Fox L(C), Ollech JE(C), Ollech A(C), Peled N(C), Kramer
MR(C). Diagnostic Value of Complement Components in Pleural Fluid:
Report of 135 Cases.
Respiratory Medicine, 102(11):1631-5, 2008.
(PMID: 18653322; RESPIRATORY SYSTEM 21/43 IF:2.33)
Times Cited: 4 (from Web of Science)
39.
Shitrit D(PI), Peled N(C), Bishara J(C), Priess R(C), Pitlik S(C), Samra Z(C),
Kramer MR(C).
Clinical and radiological features of Mycobacterium Kansasii infection
and Mycobacteruim Simiae infection.
Reapiratory Medicine, 102(11):1598-603, 2008.
(PMID: 18619826; RESPIRATORY SYSTEM 21/43 IF:2.33)
Times Cited: 5 (from Web of Science)
40.
Peled N(PI), Bendayan D(C), Shitrit D(C), Fox B(C), Yehoshua L(C), Kramer
MR(C).
Peripheral endothelial dysfunction in patients with pulmonary arterial
hypertension`. Respiratory Medicine; 102(12):1791-6, 2008.
(PMID:18678478; RESPIRATORY SYSTEM 21/43 IF:2.33)
Times Cited: 8 (from All Databases)
41.
Eli Peled(C), Naama Yoffe(C), Israel Blumenfeld(C), Nir Peled(PI).
Short and long-term efficacy of dental device in sleep apnea.
Laryngoscope, 119(3):585-8, 2009.
(PMID: 19235757; OTORHINOLARYNGOLOGY 7/36; IF:2.018).
Times Cited: 2 (from All Databases)
42.
Peled N(PI), Flex D(C), Raviv Y(C), Fox BD(C), Shitrit D(C), Refaeli Y(C),
Sauté M(C), Amital A(C), Kramer MR(C).
The role of routine bronchoscopy for early detection of bronchial stump
recurrence of lung cancer– 1 year post surgery.
Lung Cancer, 65:319–323, 2009.
(PMID: 19144443; RESPIRATORY SYSTEM 10/43; IF:3.140).
Times Cited: 2 (from All Databases)
43.
Shitrit D(PI), Rusanov V(C), Peled N(C), Amital A(C), Fuks L(C), Kramer
MR(C).
The 15-step oximetry test: a reliable tool to identify candidates for lung
transplantation among patients with idiopathic pulmonary fibrosis.
J Heart and Lung Transplantation 28(4):328-33, 2009.
(PMID: 19332258; TRANSPLANTATION 5/24 IF:3.541).
Times Cited: 7 (from All Databases)
44.
Nir Peled(PI), David Shitrit(C), Benjamin D Fox(C), Leonardo Fux(C), Anat
Amital(C), Daniele Bendayan(C), Mordechai R. Kramer(C).
Peripheral arterial stiffness and endothelial dysfunction in idiopathic and
21
Nir Peled MD PhD FCCP
scleroderma associated pulmonary arterial hypertension.
The J of Rheumatology, 36(5):970-975, 2009.
(PMID: 19369472; RHEUMATOLOGY 10/26; IF:3.854).
Times Cited: 15 (from All Databases)
45.
Shitrit D(PI), Amital A(C), Peled N(C), Raviv Y(C), Medalion B(C), Saute M(C),
Kramer MR(C).
Lung transplantation in patients with scleroderma: case series, review of
the literature, and criteria for transplantation.
Clinical Transplantation 23(2):178-83, 2009.
(PMID: 19210528; SURGERY 50/167; IF:2.004).
Times Cited: 26 (from All Databases)
46.
Adams O(C), Peled N(PI), Hirsch FR(C), Haick H(C).
Sniffing the Unique “Odor Print” of Non-Small Cell Lung Cancer by Gold
Nanoparticles.
Small; 24;5(22):2618-2624, 2009.
(PMID: 19705367; PHYSICS, APPLIED 7/108; IF:6.171).
Times Cited: 32 (from All Databases)
47.
Benjamin Fox(PI), Mordechai Kramer(C), Zohar Mor(C), Rachel Preiss(T),
Victoria Rusanov(C), Leonardo Fuks(C), Nir Peled(C), Ilanit Haim(C), Meir
Raz(C), David Shitrit(C).
The QuantiFERON TB-GOLD assay for tuberculosis screening in
healthcare workers - A cost-comparison analysis.
Lung, 187(6):413-419, 2009.
(PMID: 19830489; RESPIRATORY SYSTEM 31/43; IF:1.583).
Times Cited: 10 (from All Databases)
48.
Nseir W (PI), Giladi M(C), Moroz I(C), Moses AE(C), Benenson S(C), Finkelstein
R(C), Dan M(C), Chazan B(C), Bishara J(C), Ben-Dror G(C), Hassin D(C), Peled
N(C), Rahav G(C), Grupper M(C), Potasman I(C); Israeli Group for Study of
Pasteurella Infections.
A retrospective six-year national survey of P. multocida infections in Israel.
Scand J Infect Dis. 41(6-7):445-9, 2009.
(PMID: 19452350; INFECTIOUS DISEASES 44/57; IF:1.700).
Times Cited: 1 (from All Databases)
49.
Shlomi D(PI), Kramer MR(C), Fuks L(C), Peled N(C), Shitrit D(C).
Endobronchial drainage of lung abscess: The use of laser.
Scand J Infect Dis. 42(1):65-68, 2010.
(PMID: 19883156; INFECTIOUS DISEASES 44/57; IF:1.700).
Times Cited: 3 (from All Databases)
50.
Yasufumi Kato(PI), Nir Peled (first co-author) (PI), Murry W. Wynes(C),
Koichi Yoshida(C), Marta Pardo(C), Celine Mascaux(C), Tatsuo Ohira(C),
Masahiro Tsuboi(C), Jun Matsubayashi(C), Toshitaka Nagao(C), Norihiko
22
Nir Peled MD PhD FCCP
Ikeda(C), Fred R. Hirsch(C).
Novel
EGFR
mutation
specific
antibodies
for
NSCLC:
Immunohistochemistry as a possible screening method for EGFR
mutations.
Journal of Thoracic Oncology, 5(10):1551-8, 2010.
(PMID: 20697298; RESPIRATORY SYSTEM 5/43; IF:4.547).
Times Cited: 28 (from All Databases)
51.
Kundel Y(PI), Brenner R(C), Purim O(C), Peled N(C), Idelevich E(C), Fenig
E(C), Sulkes A(C), Brenner B(C).
Is local excision after complete pathological response to neoadjuvant
chemoradiation for rectal cancer an acceptable treatment option?
Dis Colon Rectum 53(12):1624-31, 2010.
(PMID: 21178856; SURGERY 36/167; IF:2.536)
Times Cited: 10 (from All Databases)
52.
Doebele RC(PI), Oton BA(C), Peled N(C), Camidge DR(C), Bunn AP(C).
New strategies to overcome limitations of reversible EGFR tyrosine kinase
inhibitor therapy in non-small cell lung cancer.
Lung Cancer, 69(1):1-12, 2010.
(PMID: 20092908; RESPIRATORY SYSTEM 10/43; IF:3.140).
Times Cited: 18 (from All Databases)
53.
Benjamin D Fox(PI), Michael Kassirer(C), Israela Weiss(C), Yael Raviv(C),
Nir Peled(C), David Shitrit(C), Mordechai R Kramer(C).
Ambulatory rehabilitation improves exercise capacity in patients with
pulmonary hypertension.
Journal of Cardiac Failure, 17(3):196-200, 2011.
(PMID: 21362526; CARDIAC & CARDIOVASCULAR SYSTEMS 27/95;
IF:3.254).
Times Cited: 2 (from All Databases)
54.
Orna Barash(PI), Nir Peled (first co-author)(PI), Ulrike Tisch(C), Paul A.
Bunn Jr. R. (C), Fred R. Hirsch(C), Hossam Haick(C).
Classification of the Lung Cancer Histology by Gold Nanoparticle
Sensors.
NanoMedicine, 8(5): 580-589, 2012.
(PMID:22033081; NANOSCIENCE & NANOTECHNOLOGY 13/63;
IF:4.882)
Times Cited: 8 (from All Databases)
55.
Goldberg-Stern H, Oren H, Peled N, Garty BZ.
Effect of Melatonin on Seizure Frequency in Intractable Epilepsy: A Pilot
Study.
J Child Neurology 27(12):1524-8; 2012.
(PMID: 22378657; PEDIATRICS 43/113; IF: 1.748)
Times Cited: 1 (from All Databases)
23
Nir Peled MD PhD FCCP
56.
Nir Peled(PI), Radu Ionescu(C), Pauline Nol(C), Orna Barash(C), Matt
McCollum(C), Kurt VerCauteren(C), Matthew Koslow(C), Randal Stahl(C),
Jack Rhyan(PI), Hossam Haick(PI).
Detection of Volatile Organic Compounds in Cattle Naturally Infected with
Mycobacterium bovis.
Sensors & Actuators: B. Chemical, 171-172:588-594, 2012.
(PMID: ; CHEMISTRY, ANALYTICAL 13/71; IF:3.368)
Times Cited: 0 (from All Databases)
57.
Nir Peled(PI), Meggie Hakim, Paul A. Bunn Jr. R., York E. Miller, Timothy
C Kennedy, Jane Mattei, John D Mitchell, Michael J. Weyant, Fred R.
Hirsch, Hossam Haick.
Non-Invasive Breath Analysis for Solitary Pulmonary Nodules.
Journal of Thoracic Oncology, 7:1528-1533, 2012.
(PMID: 22929969; RESPIRATORY SYSTEM 5/43; IF:4.547).
58
Meggie Hakim, Yoav Y. Broza, Barash Orna, Nir Peled(C), Michael
Phillips, Anton Amann, Hossam Haick(PI).
Formation of volatile organic compounds associated with lung cancer and
possible biochemical pathways (Peer Review).
Chemical Reviews, 14;112(11):5949-66, 2012.
(PMID: 22991938; CHEMISTRY, MULTIDISCIPLINARY 1/152; IF:
40.197)
59
Alon Abraham(PI), Nir Peled(C), Alexander Khebtovsky(C), Felix
Benninger(C), Israel Steiner(C), Hadass Kalish Stiebel(C), Ruth Djaldetti(C).
Nocturnal carbon dioxide monitoring in patients with idiopathic intracranial
hypertension.
Clinical neurology and neurosurgery, 115(8):1379-81, 2013.
(PMID: 23369399; SURGERY 80/199; IF: 1.581)
60
Nir Peled(PI), Orna Barash, Ulrike Tisch, Radu Ionescu, Maya Ilouze, Jane
Mattei, Paul A. Bunn Jr R., Fred R. Hirsch, and Hossam Haick.
Volatile Fingerprints of Cancer Specific Genetic Mutations.
Nanomedicine: Nanotechnology, Biology and Medicine, 9(6):758-66,
2013.
(PMID: 23428987; NANOTECHNOLOGY, BIOLOGY AND MEDICINE.;
IF: 6.69)
61
Nir Peled(PI), Murry W. Wynes, Norihiko Ikeda, Tatsuo Ohira, Koichi
Yoshida, Jin Qian, Maya Ilouze, Ronen Brenner, Yasufumi Kato, Celine
Mascaux, Fred R Hirsch.
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for
resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung
cancer.
Cellular Oncology, 36 (4): 277-288, 2013.
24
Nir Peled MD PhD FCCP
(PMID: 23619944 ; PATOLOGY 17/79.; IF: 3.105)
62
Dekel Shlomi, Amir Onn, Maya Gottfried, Jair Bar, Haim Biran, Maya
Ilouze, Hovav Nechushtan, Lior Soussan-Gutman, Nir Peled.
Better Selection Model for EML4-ALK Fusion Gee Test in Patients with
Non-Small-Cell Lung Cancer.
J Cancer Therapy, 4: 54-58, 2013.
63.
Ronen Brenner, Shaye Kivity, Yulia Kundel, Ofer Purim, Nir Peled, Efraim
Idelevich, Konstantin Lavrenkov, Svetlana Kovel, Eyal Fenig, Aaron
Sulkes, Baruch Brenner.
Ethnic Variation in Toxicity and Outcome of Adjuvant Chemoradiation for
Gastic Cancer in Israel.
Anticancer Research, 33:5151-5157, 2013.
(PMID: ; 24222163.; IF: )
64.
Gingold-Belfer R, Peled N, Levy S, Katz N, Niv Y, Fass R, Fraser G,
Dickman R.
Impaired Sleep Quality in Crohn's Disease Depends on Disease Activity.
Digestive Disease Science, 59(1):146-151, 2014.
(PMID: 24114045;).
B.1. Articles Submitted
1.
B.2. CASE REPORTS
1.
Kramer MR(PI), Peled N(C), Shitrit D(C), Atar E(C), Saute M(C), Shlomi D(C),
Amital A(C), Bruckheimer E(C).
Use of Amplatzer Device for Endobronchial Closure of Bronchopleural
Fistulas.
Chest; 133 (6):1481-4, 2008.
(PMID: 18574292; RESPIRATORY SYSTEM 3/43; IF:6.360).
Times Cited: 14 (from All Databases)
2.
Shani Atia, Alon Ben Noon, Tatiana Rabin, Nir Peled(PI).
Ectopic Pregnancy as a presenting symptom for Lung Cancer.
Harefuah 151(7): 398-401, 436, 2012.
(PMID: 23002689)
Times Cited: 0 (from All Databases)
25
Nir Peled MD PhD FCCP
3.
Nir Peled, Gary Palmer, Fred R. Hirsch, Murry W. Wynes, Maya Ilouze,
Marileila Varella-Garcia, Lior Soussan-Gutman, Geoff A. Otto, Philip J.
Stephens, Jeffrey S. Ross, Maureen T. Cronin, Doron Lipson, Vincent A.
Miller.
Next Generation Sequencing Identifies and Immunohistochemistry
Confirms a Novel Crizotinib Sensitive ALK Rearrangement in a Patient
with Metastatic Non-small Cell Lung Cancer.
Journal of Thoracic Oncology, 7(9):e14-6, 2012.
(PMID: 22895149; RESPIRATORY SYSTEM 5/43; IF:4.547).
Times Cited: 3 (from All Databases)
4.
Nir Peled, Leor Zach, Ori Liran, Maya Ilouze, Paul A. Bunn Jr, Fred R.
Hirsch.
Effective Crizotinib Schedule for Brain Metastases in ALK Rearrangement
Metastatic Non-small Cell Lung Cancer.
Journal of Thoracic Oncology, 8(12):e112-113, 2013.
(PMID: 24389447; RESPIRATORY SYSTEM 5/43; IF:4.547).
B.3. REVIEW ARTICLES
1.
Pillar G(PI), Sade A(C), Peled N(C), Peled R(C), Lavie P(C).
Insomnia in infancy and childhood - causes, significance, assessment and
approach to treatment.
Harefuah 130(4): 255-260, 1996.
(PMID: 8675120)
2.
Peled N(PI), Pillar G(C), Peled R(C), Lavie P(C).
Narcolepsy.
Harefuah 133(2): 43-47, 1997.
(PMID: 9332058
3.
Peled N(PI), Nakar C(C), Ashkenazi S(C), Merlov P(C).
Antenatal follow-up and the attitude to a newborn of mother with a positive
VDRL test - Review.
Harefuah, 140: 75-79, 2001.
(PMID: 11303358;
4.
Peled N(PI), Oton AB(C), Hirsch RF(C), Bunn P(C).
MAGE A3 Antigen-Specific cancer Immunotherapeutic.
Immunotherapy 1 (1): 19-25, 2009.
(PMID: 20635969; ONCOLOGY 58/166; IF:3.203).
Times Cited: 12 (from All Databases)
26
Nir Peled MD PhD FCCP
5.
Peled N(PI), Yoshida K(C), Wynes MW (C), Hirsch FR(C).
Predictive and prognostic markers for EGRF inhibitor therapy in Non-Small
Cell Lung Cancer.
Therapeutic Advances in Medical Oncology; 1(3):137-144, 2009.
(PMID: 20843203)
Times Cited: 3 (from All Databases)
6.
Celine Mascaux(PI), Nir Peled(PI), Kavita Garg(C), Yasufumi Kato(C), Murry
Wynes(C), Fred R Hirsch(C).
Early Detection and Screening of Lung Cancer.
Epxert Review Molecular Diagnosis 10(6): 799-815, 2010.
(PMID: 20843203; PATHOLOGY 13/71; IF:3.693).
Times Cited: 9 (from All Databases)
7.
Ulrike Tisch, Nir Peled, Salem Billan, Michael Phillip, Maya Ilouze, Hossam
Haick.
Volatile Biomarkers in the Exhaled Breath for the Early Detection and
Screening of Lung Cancer.
Current Medical Literature – Lung Cancer 5(4):107-17, 2012.
8.
Dekel Shlomi, Marina Pekar, Maya Ilouze, Jair Bar, Haim Biran, Rossie
Navon, Amir Onn, Nir Peled.
The Diagnostic Puzzle of EML4–ALK Rearrangement in Lung Cancer.
The Journal of OncoPathology, In Press, February 2013.
9.
Marina Peker, Amir Onn, Lior Soussan-Gutman, Nir Peled.
Lung Cancer – immediated implications of Biomarker for Personalized
Medicine (Hebrew).
Medical Media, 2:24-27, 2013.
C. CHAPTERS IN BOOKS
1.
Nir Peled, Keith Robert, Fred R Hirsch.
Lung Cancer prevention and chemoprevention. In: Lung Cancer: Prevention,
Management and Emerging Therapies. Editors: David Johnson and John
Minna; US; 2009, pp 107-140.
2.
Nir Peled and Fred Hirsch.
The clinical use of Biomarkers in lung cancer. In: Lung Cancer. Editors: Fred
R Hirsch, Peter Harper. Remedica, State of the Art Series, 2010. Pp: 207232.
3.
Celine Mascaux, Nir Peled, Fred R Hirsch.
Molecular diagnostic for the clinician: The essentials; In: Clinical Care
Options (CCO) inPractice CME program. August 2009.
27
Nir Peled MD PhD FCCP
4.
Nir Peled, Celine Mascaux, Murry W Wynes, Fred R Hirsch. Role of
Personalized Medicine: Now and the Future. In: Multidisciplinary Oncology:
Lung Cancer, edited by Kemp Kernstine, MD, and Karen Reckamp, MD (A
volume in Current Multidisciplinary Oncology series, edited by Charles R.
Thomas, Jr., MD); Demos Medical Publishing, NY. August 2011 pp 263276.
5.
Paul Bunn, York Miller, Nir Peled, Ali Musani, Kavita Garg, Wilbur Franklin,
Fred Hirsch, John Mitchell, Michael Weyant, ross Camidge, Robert Doeble,
Laurie Gaspar, Brian Kavanagh, TG Pugh, Jessica Flagiello.
Multidisciplinary Care of Patients with Lung Cancer. In: Multidisciplinary
Oncology: Lung Cancer, edited by Kemp Kernstine, MD, and Karen
Reckamp, MD (A volume in Current Multidisciplinary Oncology series, edited
by Charles R. Thomas, Jr., MD); Demos Medical Publishing, NY. August
2011 pp 353-358.
D.1.INVITED PRESENTATIONS IN SCIENTIFIC MEETINGS
2007
The 3rd Annual Update Symposium Series on Clinical Neurology and
Neurophysiology, Tel Aviv, Israel February 2007 – Obstructive Sleep
Apnea
Syndrome
and
Stroke:
Clinical
manifestations,
pathophysiology,
cognitive,
cardiovascular
and
metabolic
complications, relation to stroke.
2008
Annual Lung Cancer Symposium; Beaumont Cancer Center; Royal
Oak and Troy, Birmingham, Michigan– “Biomarker in the treatment of
lung cancer”; November 7th, 2008.
2008
Lung/Head and Neck Cancer Seminar Series- SPORE meeting;
Anchuz Medical Center, University Colorado Denver; – “Volotile
Organic Compuond as a biomarker for Lung cancer”; May 4 th, 2008.
2009
Grand round, Presbyterian/St.Luke’s Medical Center, Denver
Colorado – “Exhale breath for detecting lung cancer”; May 5, 2009.
2009
British Columbia Cancer Research Center, Vancouver Canada,
Invited seminar, modulated by Prof Stephen Lam - “Exhaled breath
as a biomarker for lung cancer – nano-technology approach”; May 8th,
2009.
2009
Weizmann Institute of Science, Department of Biological Regulation,
Rehovot Israel, Invited Seminar, modulated by Prof Yossi Yarden–
“Exhaled breath nano-analysis for early detection of lung cancer”,
July 16th 2009.
28
Nir Peled MD PhD FCCP
2009
Uniersity of Colorado Denver, Division of Medical Oncology; Aurora,
Colorado, USA. Research in Progress Seminar: Sniffing the Cancer?
Yes, it works !!. September 24th 2009.
2009
Uniersity of Colorado Denver, UCCC Symposium Series, Invited
Symposium, Aurora Colorado, USA – “Diagnosis of Cancer via
Breath Samples Using Arrays of Nanosensors”, December 1st 2009.
2010
The CHEST 2010 ACCP meeting; Invited lecture. Title: Biologic
Markers and Volatile Markers: Analysis – Oral. November 4th, 2010.
2011
The Second Annual Westcliffe Pulmonary Conclave; Westcliffe,
Colorado; USA - "New technologies in early detection and diagnosis
of lung cancer", June 2011.
2011
The 14th World Conference of Lung Cancer (IASLC); Amsterdam,
Neatherland, July 2011. Breath test as a Biomarker for Cancer, Lung
Cancer Biomarker Workshop, Chair & Speaker.
2011
The 25th International Conference on Screening for Lung Cancer
(I-ELCAP) - The electronic Nose for early detection of lung cancer.
Jerusalem, Israel, October, 2011 - Invited Speaker.
2012
Baptist Health Medical Center. Orlando, Florida, USA. CME Lecture
“Volatile Organic Compounds and the early detection of lung Cancer”,
January 12, 2012.
2012
IRSUSAL01, an international protocol to correlate the utility of
PETCT, serum, sputum, and breath technologies to improve early
detection and cure rates in lung cancer; Epping Forest Yacht Club;
Jacksonville, Florida, USA. January 12, 2012.
2012
FIRST JOINT MEETING ACCP and Israel Society of Pulmonary
Medicine (ISP). Diagnosis of Malignant and Benign Conditions from
Exhaled Breath. Tel Aviv, Israel. March, 2012.
2012
Healthworker Safety Symposium – Past, Present and Future. Rabin
Medical Center, Petach Tiqwa, Israel. Cytotoxic Drugs Exposure
Among Healthcare Workers - Biomarkers to Quantify DNA Damage
and Risk for Cancer Development. October 31st, 2012.
2012
The Israeli Chest Physician Monthly Meeting. Seeking for molecular
diagnoses. How far should we go? Tel Aviv, Israel. December 19th,
2012.
2012
Translating Emerging Molecular Data Into Clinical Practice. Predictive
Onclogoy Conference. Novel Crizotinib-Sensitive ALK rearrangement
in a patient with metastatic non-small-cell lung cancer. Plennary talk,
Tel Aviv, Israel. December 21st , 2012.
29
Nir Peled MD PhD FCCP
2013
Updates in Non Invasive Biomarkers for Lung Cancer Early
Detection. Epping Forest Yacht Club; Jacksonville, Florida, USA.
January 25th, 2013.
2013
The International Society for Olfactory and Chemical Sensing Annual
Meeting; Wallerfangen, Germany. Invited Speaker: A Comrehensive
Review of Lung Cancer – Understandign the UNMET need in Lung
Cancer Diagnoses. June 14, 2013.
2013
The Israeli Chest Physicians Annual Scientific Meeting. EML4-ALK
Gene Rearangement in NSCLC Patients – The Hidden 50%. Tel
Aviv, Israel. June 19th, 2013.
2013
Corsos de Verano; Summer Seminar by UNIVERSIDAD
COMPLUTENSE MADRID; San-Lorenzo de El-Escorial, Spain.
“Novel Technologies for Early Detection Of Lung Cancer”. July 2 nd
2013.
2013
The European Respiratory Society. Barcelona, Spain. September 712, 2013. (Oral + Chairmen of Early Detection session)
2013
Invitation by Prof Tony Mok, IASLC Head, to the Department of
Clinical Oncology, the Chinese University of Hong Kong, Sir YK Pao
Centre for Cancer. November 5-7, 2013.
2013
The 1st Indian Cancer Conference, Invited Talk, Chairman and
Round Table leader, New Delhi, November21st-24th, 2013.
Educational: Adjuvant and Neoadjuvant Treatment of lung cancer;
Case Discussions (As an Expert); Round Table Genomics in cancer is it ready for prime time.
2014
The 13th Annual Meeting of the Israeli Society for Clinical Oncology
and Radiotion Therapy; January, 14-17, 2014. Targeted therapy in
lung cancer – Translating the art into.
D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED
AS PROCEEDINGS
D.3. ABSTRACTS (Partial list)
1. The 6th international congress on ambulatory monitoring, Barcelona,
Spain (May 1994):
a. Peled Nir, Abinader Edward, Sharif Dawod, Pillar Giora, Lavie Peretz.
Cardiac ischemic events in sleep apnea syndrome - Poster.
30
Nir Peled MD PhD FCCP
2. The 12th European Sleep Research Society Congress, Fierenze, Italy
(May 1994):
a. Peled N, Lavie P. Monitoring operator's performance - the role of
blinking - Poster.
b. Peled N, Zinder O, Greenberg A, Levi N, Lavie P. Catecholeamines
and blood pressure in sleep apnea syndrome - Poster.
3. Fourth Word Congress on Sleep Apnea 1994, San Francisco,
California,
USA (October 1994):
a. N Peled, Edward Abinader, Dawod Sharif, Pillar Giora, Peretz Lavie.
Sleep apnea increases oxygen consumption by the myocard Poster.
4. The 2nd Meeting of The Israeli Society for Biological Psychiatry, Kfar
Giladi, Israel (March 1995):
a. N. Peled, G. Pillar, O.J. Kwon, A. Amar, C. Brautbar, R. Peled, and P.
Lavie. Molecular HLA Typing in Israeli Narcoleptic Patients - Oral.
5. The 9th APSS Annual Meeting, Nashville, Tennessee, USA (June
1995):
a. Nir Peled, Giora Pillar, OJ Kwon, Avraham Amar, Chaim Brautbar,
Ron Peled, Peretz Lavie. Molecular HLA typing in Israeli narcoleptic
patients – Oral.
6. The 1st Congress of the Israeli Sleep Research Society, Netania,
Israel (Nov. 1995):
a. Nir Peled, Giora Pillar, Avraham Amar, Chaiim Brautbar, O-Jun Yang,
Peretz Lavie. HLA-DRB1*1501, DQA1*0102 and DQB1*0602 in
Israeli Narcoleptics - Poster.
b. Nir Peled, Edward Abinader, Giora Pillar, Dawood Sharif, Peretz
Lavie. Sleep Apnea as a cause of Cardiac Ischemia at night Poster.
7. The 8th International Rappaport Congress and the 2nd Israeli Sleep
Research Society Meeting, Zichron Yaacov, Israel (March 1997):
a. Nir Peled, Dawood Sharif, Giora Pillar, Edward Avinader, Peretz
Lavie. Does sleep apnea syndrome exacerbate ischemic heart
disease ?
8. The 3rd Annual Meeting of the Israeli Sleep Research Society, Beer
Sheva, Israel (March 1998).
a. Nir Peled, Edward Abinader, Giora Pillar, Dawood Sharif, Peretz
Lavie. Does sleep apnea syndrome cause cardiac ischemia during
sleep ? - Oral.
9. The XIII Word Congress of Cardiology, Rio de Janeiro, Brazil (April
1998):
a. Edward G. Abinader, Nir Peled, Dawod Sharif, Giora Pillar, Peretz
Lavie. Myocardial ischemia in the sleep apnea syndrome - Poster.
31
Nir Peled MD PhD FCCP
10. The Annual meeting of the Israeli Heart Society, Jerusaelm, ISRAEL,
April 1998:
a. N. Peled, E. Abinader, G. Pillar, D. Sharif, P. Lavie. Reversible night
ischemic events due to comorbidity of sleep apnea syndrome and
ischemic heart disease – Poster.
11. The 14th Congress of the European Sleep Research Society, Madrid,
Spain (September 1998):
a. Nir Peled, Edward Abinader, Giora Pillar, Dawood Sharif, Peretz
Lavie. Sleep Apnea Syndrome and Cardiac Ischemia with and
without CPAP Treatment - Oral.
12. 1999 ALA/ATS International Conference, San Diego, California, USA
(April 1999):
a. Y. Adir, A Schupak, A. Gil, N. Peled and D. Weiler-Ravell. Clinical
presentation of swimming induced pulmonary edema (SIPE) – A
series of 70 cases.
13. The 51st Annual Conference of the Israel Heart Society, Tel-Aviv
(April 2004).
a. N Peled, S Pitlik, S Ashkenazi, A Sagie, J. Bishara. Long-term
outcome of Infective Endocarditis: The role of Age- Oral.
16. The Interim Congress of World Federation of Sleep Research and
Sleep Medicine Societies, New Delhi, India (September 2005):
a. N Peled, D Shitrit, MR Kramer. Vascular endothelial growth factor in
obstructive sleep apnea syndrome - Oral.
17. The Annual Scientific Meeting of the Israeli Society of Pulmonolgy
and the Israeli Society of Thoraci Surgery, Deat sea, Israel (March
2006):
a. Peled N, Kasirer M, Shitrit D, Kogan Y, Berliner AS, Kramer MR.
Obstructive sleep apnea and the metabolic syndrome – Oral.
18. The Annual International Conference of the American thoracic
Society, San Diego, California (May 2006):
a. Peled N, Kassirer M, Shitrit D, Berliner AS, Kramer MR. Metabolic
syndrome profile in obstructive sleep apnea syndrome – Poster.
19. The Annual International Conference of the Eropean Thoracic
Society, Minch, Germany (September 2006):
a. Shlomi D, Peled N, Shitrit D, Bendayan D, Amital A, Kramer MR.
Protective effect of immunosupression on granulation tissue
formation in metallic airway stents – Oral.
20. The 8th Annual Meeting of the Israeli Sleep Research Society, HaifaIsrael, Israel (November 2006).
a. Nir Peled, Micha Kassirer, David Shitrit, Dekel Shlomi, Abraham
Shlomo Berliner, Mordechai Reuven Kramer. The role of OSA in
the increased incidence of the metablic syndrome - Oral.
21. The 3rd Annual Update Symposion Series on Clinical Neurology and
NeuroPhysiology, Tel Aviv, Israel (February 2007):
32
Nir Peled MD PhD FCCP
a. Obstructive Sleep Apnea Syndrome and Stroke: Clinical
manifestations, pathophysiology, cognitive, cardiovascular and
metabolic complications, relation to stroke – Oral.
22. The Annual Scientific Meeting of the Israeli Society of Pulmonolgy
and the Israeli Society of Thoraci Surgery, Keisaria, Israel (May 2007):
a. N Peled, M Kassirer, O Rogowski, D Shlomi, B Fox, AS Berliner, MR
Kramer, D Shitrit. Increased erythrocyte adhesiveness and aggregation
in OSA – Oral.
23. The SLEEP 2007 Meeting (APSS), Minneapolis, MN, USA (June
2007):
a. N Peled, M Kassirer, O Rogowski, D Shlomi, B Fox, AS Berliner, MR
Kramer, D Shitrit. Increased erythrocyte adhesiveness and aggregation
in OSA – Oral & Young Investigator Honor Mention Award.
24. The European Respiratory Society Annual Congress 2007,
Stockholm, Sweden (September 2007):
a. N Peled, Bendayan D, Shitrit D, Fox B, Kramer MR. Peripheral
endothelial dysfunction in patients with pulmonary artery hypertension Poster.
25. The 10th Annual Meeting of the Israeli Sleep Research Society, BeerSheva, Israel (December 2007).
a. N Peled, M Kassirer, O Rogowski, D Shlomi, A Berliner, D Shitrit, MR
Kramer. Erythrocyte adhesiveness and inflammation in OSAS - Oral.
26. The Annual 7th Meeting of the Israeli Society for Clinical Oncology
and radiation Therapy, Eilat, Israel (January 2008).
a. Y Kundel, E Idelevich, R Brenner, A Abramovich, O Purim, N Peled, N
Wasserberg, B Nisenbaum, N Karminsky, E Fenig , A Sulkes, B
Brenner . Restaging after preoperative chemoradiation for rectal cancer
- can it actually predict histological response to treatment?
27. The 44th Annual Meeting of the American Society of Clinical
Oncology, Chicago, USA, 2008.
a. Y. Kundel, R. Brenner, A. Abramovich, O. Purim, N. Peled, E.
Idelevich, B. Nisenbaum, E. Fenig, A. Sulkes, B. Brenner.
Prognostic factors for tumor histological response to preoperative
chemoradiation in rectal cancer. J Clin Oncology; Vol 26, No 15S
(May 20 Supplement), 2008: 4094
28. The European Society for Medical Oncology Conference, Lugano,
Switzerland, 2008.
a. R. Brenner, Y. Kundel, E. Idelevich, A. Abramovich, O. Purim, N.
Peled, N. Wasserberg, B. Nisenbaum, N. Karminsky, E. Fenig, A
Sulkes ,B Brenner. Restaging after preoperative chemoradiation for
rectal cancer - can it actually predict histological response to
treatment?
29. The 33rd ESMO Congress, Stockholm, Sweden 12-16 September
2008.
33
Nir Peled MD PhD FCCP
a. R. Brenner, Y. Kundel, O. Purim, N. Peled, E. Idelevich, K.
Lavrenkov, S. Kovel, E. Fenig, A. Sulkes, B. Brenner. Comparison
of toxicity, tolerability and outcome between ashkenazi and
separadoc hews in israel receiving postoperative chemoradiation
for locally advanced gastric cancer.
30. The 2009 ATS International Conference in San Diego, CA, USA (May
2009).
a. Peled N, Flex D, Raviv Y, Fox BD, Shitrit D, Refaeli Y, Sauté M,
Amital A, Kramer MR. The Role of Routine Bronchoscopy for Early
Detection of Bronchial Stump Recurrence of Lung Cancer - 1 Year
Post Surgery.
31. The 2009 IASLC International Conference in San Francisco, CA, USA
(July 2009).
a. Peled Nir, Orna Adams, Koichi Yoshida, Paul Bunn, Hossam Haick,
Fred Hirsch. The unique “smell print” of NSCLC cell lines – Oral and
Press released.
b. M.W. Wynes , N. Peled, R. Dziadziuszko, W.C. Powell, J. Jassem,
M. Pardo, X.L. Yin, F.R Hirsch. Comparative analysis and
prognostic association of EGFR protein expression with survival
using a novel antibody specific for the intracellular domain of EGFR
– e poster.
32. The 2010 IASLC UC Denver Cancer Center Retreat in Westminster,
CO, USA (March 2010).
a. Celine Mascaux, Nir Peled, Fred R Hirsch. Biomarkers for the early
detection and screening of lung cancer –Poster Session Awards.
b. M.W. Wynes , Yasufumi Kato, Celine Mascaux, N. Peled, Samir
Witta, Jin Qian, Cindy Tran, F.R Hirsch. Predictive and Prognostic
Biomarkers in Lung Cancer – Poster.
33. The 2010 ASCO International Conference in Chicago, IL, USA (May
2010).
a. Nir Peled, Meggie Hakim, Hossam Haick, Paul A. Bunn Jr R, York
Miller, Timothy Kennedy, Michael Wayent, John Mitchell, Fred R
Hirsch. Detecting NSCLC in the nodule clinic using nanopartivcle
based artificial olfactory system NaNose® - Abstract No: 10521; Poster
Discussion and Awarded for the “2010 ASCO Cancer Foundation
Merit Award” for its recognition of outstanding abstracts submitted
to the Scientific Program Committee. Journal of Clinical
Oncology, 2010 ASCO Annual Meeting Proceedings; Vol 28
(15suppl), 2010: 10521
b. Yasufumi Kato, Nir Peled, Fred R Hirsch. Immunohistochemistry
detection of epidermal growth factor receptor (EGFR) exons 19 and
21 mutations in non-small cell lung cancer (NSCLC) using novel
mutation specific antibodies – Abstract No: 10542; Poster.
34
Nir Peled MD PhD FCCP
c. B. Brenner, R. Brenner, O. Puirm, N. Peled, E. Idelevich, B.
Nisenbaum, E. Fenig, A. Sulkes. Local excision after neoadjuvant
chemoradiation for rectal cancer: Is it an acceptable treatment
option? Abstract No: 3646; Poster.
34. The 2010 CHEST International Conference in Vancouver BC, Canada
(November 2010).
a. Nir Peled. Biologic Markers and Volatile Markers: Analysis – Oral.
b. Session Title: Early Detection of Lung Cancer: Is There a True
Divining Rod? Pannel Discussion; November 4th 2010.
35. The 14th World Conference of Lung Cancer (IASLC); Amsterdam,
Neatherland, July 2011.
a. Hossam Haick, Nir Peled, Peng Gang, Orna Barash, Meggie Hakim,
Ulrike Tisch, Paul A. Bunn JrR, Fred R. Hirsc. The unique “smell
print” of NSCLC cell lines – Oral and Press released.
36. The 25th International Conference on Screening for Lung Cancer. IELCAP; Jerusaelm, Israel, October 2011.
a. Nir Peled. The electronic nose for early detection of lung cancer –
Oral (Invited).
37. The AACR-IASLC Joint Conference on Molecular Origins of Lung
Cancer: Biology, Therapy, and Personalized Medicine; San Diego,
CA USA. January 2012
a. Nir Peled, Meggie Hakim, Ulrike Tisch, Paul A. Bunn Jr. R., York
E.Miller, Timothy C Kennedy, Jane Mattei, John D Mitchell, Michael
J. Weyant, Fred R. Hirsch, Hossam Haick. Breath Biomarkers in
the Post NLST-era for the Discrimination between Malignant from
Benign Pulmonary Nodules (Poster + Press Review).
b. Assaf Zohar, Nir Peled, Orna Amir, Michal Alumot-Yehoshua,
Marina Kleiman. NSCLC personalized medicine via integration into
bio-mathematical
model
individual
clinical
data
and
prognostic/predictive biomarkers.
38. The American Association for Cancer Research (AACR) Meeting;
Chicago, USA, April 2012.
a. Dilara McCauley, Tami Rashal, Sharon Shacham, Michael
Kauffman, Yossi Landesman, Jean St-Martin, Trinayan Kashyap,
William Senapedis, Jennifer L. Williams, Raphael Nir, Maya Illuz,
Nir Peled.
Selective inhibitors of nuclear export (SINE) induce
multiple tumor suppressor proteins (TSP) activity and show single
agent antitumor effect and synergy with Bcl-2 antagonist in nonsmall cell lung cancer.
39. The European Respiratory Society Congress, Vienna September
2012.
a. Maya Illuz, Nir Peled. Glycolytic Phenotype Mapping in Lung Cancer
Cell lines – Theatic Poster.
b. New aspects of lung cancer biology – Chair of Thematic Poster
Session, September 2nd 2012.
35
Nir Peled MD PhD FCCP
40. The American Association for Cancer Research (AACR) Meeting;
Washington, USA, April 2013.
a. Dilara McCauley, Tami Rashal, Sharon Shacham, Michael
Kauffman, Yossi Landesman, Jean St-Martin, Trinayan Kashyap,
William Senapedis, Jennifer L. Williams, Raphael Nir, Maya Illuz,
Nir Peled.
Combination tTerapy KPT-SINE (selective inhibitors
of nuclear export) with radiotherapy have additive effects in nonsmall cell lung cancer (NSCLC) cells in vitro and in vivo. (Abstract
Number 2071)
41. The International Society for Olfactory and Chemical Sensing Annual
Meeting; Wallerfangen, Germany. June 2013.
a. Nir Peled. Diagnostic Methods of Lung Cancer (Oral).
b. Michael Davies, Orna Barash, Raneen Jeries, Nir Peled, Maya
Ilouze, Russell Hyde, Michael Marcus, Hossam Haick, John Field.
Volatile biomarkers discriminate between bronchial epithelial cells
with distinct mutations (Oral).
42. The European Respiratory Society. Barcelona, Spain. September 712, 2013.
a. Maya Ilouze, Tali Feinberg, Ronen Shavit and Nir Peled. Metabolic
modification as a potential therapeutics approach in lung cancer
(Thematic Poster).
b. Nir Peled, Gary Palmer, Fred R. Hirsch, Murry W. Wynes, Maya
Ilouze, Marileila Varella-Garcia, Lior Soussan-Gutman, Geoff A.
Otto, Philip J. Stephens, Jeffrey S. Ross, Maureen T. Cronin, Doron
Lipson, and Vincent A. Miller. The diagnostic puzzle of ALK
rearrangement in lung cancer. A novel intron related abnormality
(Oral).
c. Marina Pekar, Maya Ilouze, Vincent Miller, Doron Lipson, Siraj Ali,
Jair Bar, Amir Onn, Dekel Shlomi, Meital Elimelech, Lior SoussanGutman, Murry Wynes, Fred Hirsch and Nir Peled. The art of
detecting EML4-ALK gene rearrangements in NSCLC patients Immediate implications for patient care (Poster).
43. The 2014 AGBT Meeting. Advanced in Genome Biology &
Technology, Florida 2014.
a. Doron Lipson, Geoff Otto, Siraj Ali, Geneva Young, Jie He, Nir
Peled, Alexander Drilon, Marc Ladanyi, Naiyer Rizvi, Jeffrey S
Ross, Roman Yelensky, Vincent A Miller and Philip J Stephens.
Clinical Next Generation Sequencing (NGS) of Advanced Lung
Cancer Reveals a High Frequency of Genomic Alterations Including
Novel Targetable Kinase Fusions.
44. The 15th World Conference of Lung Cancer (IASLC); Sydney,
Australia. October 2013.
36
Nir Peled MD PhD FCCP
a. Alan Nelson, Michael Meyer, Thomas Neumann, Jon Hayenga,
Rahul Katdare, Chris Presley, Ben Hawthorne, David Steinhauer,
Timothy Bell, Scarlett Spring, Anna Tourovskaia, Florence Patten,
Gene Pawlick, Terrance Colgan, David Wilbur, Douglas Johnson,
Nir Peled, Ralph W. Aye, Paul Zarogoulidis, Jason Chien. Noninvasive Detection of Lung Cancer from Cells in Sputum Using CellCT™. Poster.
b. Marina Pekar, Murry W. Wynes, Maya Ilouze, Mirna Knight, Vincent
Miller, Doron Lipson, Siraj Ali, Gary Plamer, Lior Soussan-Gutman,
Addie Dvir, Fred Hirsch, Nir Peled. The hidden 50% of the ALK
positive NSCLC patients. Poster.
45. The 13th Annual Meeting of the Israeli Society for Clinical Oncology
and Radiotion Therapy; January, 14-17, 2014. Eilat, Israel
a. Liran Ori, Hakim Meggie, Abud Hawa Manal, Dekel Shlomi, Ben-Nun
Alon, Onn Amir, Bar Yair, Haick Hossam & Peled Nir. Breath
Analysis as a Non-invasive Biomarker for Solitary Pulmonary
Nodules. Oral, Award as Best of ISCORT.
b. Targeted therapy in lung cancer – Translating the art into clinical
decision. Oral, Invited.
c. Pekar Marina, Wynes Murry W, Ilouze Maya, Knight Mirna, Miller
Vincent, Lipson Doron, Ali Siraj, Plamer Gary, Soussan-Gutman
Lior, Dvir Addie, Bunn Paul, Hirsch Fred & Peled Nir, The hidden
50% of the ALK positive NSCLC patients. Oral.
E. ITEMS IN ENCYLOPEDIAS
F. BOOKS EDITED
G. OTHER PUBLICATIONS (Encyclopedias; Reports; Letter to Editors)
1.
Abinader EG, Peled N, Sharif D, Lavie P.
ST-Segment depression during obstructive sleep apnea (letter).
Am J Cardiology 73(9): 727, 1994.
(PMID: 8166083; CARDIAC & CARDIOVASCULAR SYSTEMS 21/95;
IF:3.575).
37
Nir Peled MD PhD FCCP
SPECIAL PROJECTS
1. Directing and conducting the physician WEB site at Rabin Medical Center,
Petach Tiqwa, Sackler Faculty of Medicine, Tel-Aviv University, Israel, 20062007.
38